BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 133.60 |
| Open | 133.03 |
| Bid | 134.05 x 1100 |
| Ask | 137.00 x 800 |
| Day's range | 133.03 - 136.25 |
| 52-week range | 117.08 - 374.58 |
| Volume | |
| Avg. volume | 892,846 |
| Market cap | 32.733B |
| Beta (5Y monthly) | 0.03 |
| PE ratio (TTM) | 3.08 |
| EPS (TTM) | 43.77 |
| Earnings date | 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 June 2022 |
| 1y target est | 233.03 |
- Zacks
EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster
The EMA accepts Moderna's (MRNA) regulatory filing seeking authorization for bivalent COVID-19 booster vaccine, mRNA-1273.222, designed to target the Omicron BA.4 and BA.5 subvariants.
- Zacks
Pfizer (PFE), BNTX Seek EU Nod for Omicron Booster in Kids
Pfizer (PFE) and BioNTech seek to expand the EU label of their Omicron BA.4/BA.5-adapting bivalent COVID vaccine for children. It is already authorized for use in adolescents and adults.
- Yahoo Finance
COVID-19: Young, healthy people may not need bivalent boosters, vaccine expert says
Data is still scarce on latest COVID-19 boosters
© 2022 Yahoo. All rights reserved.
